Navigation Links
RPS Enhances Clinical Expertise and Leadership with Two Additions to Senior Management Team

FORT WASHINGTON, Pa., May 14 /PRNewswire/ -- RPS, Inc. today announced the addition of two new members to its Senior Management Team. David A. Green, Ph.D. joins RPS as Vice President of Clinical Operations. Neil H. Shusterman, M.D. joins RPS as Senior Vice President, Medical, Regulatory and Drug Safety.

"We are pleased that both Dr. David Green and Dr. Neil Shusterman have joined the RPS organization. Both individuals bring significant industry and drug development experience that will further enhance the depth and breadth of our clinical organizational leadership and expertise," said Harris Koffer, Pharm.D., President and Chief Operating Officer. "Under their leadership, I am confident that we will continue to expand our capabilities to provide innovative, global clinical development solutions to our customers."

David A. Green, Ph.D.

In his new role, Dr. Green will have oversight of Data Management, Statistics, Programming, Site Management and Monitoring, and Project Management.

Prior to joining RPS, Dr. Green held numerous positions of increasing scope and responsibility within the bio-pharmaceutical industry. Most recently, David served as Executive Director of Clinical Field Operations for Amgen, Inc. where he led the US Clinical Field Operations and oversaw field based trial operations across Phase I-III clinical trials and all therapeutic areas. During his tenure at Amgen he was also the Therapeutic Area Operations Lead for Diabetes/Obesity, Inflammation, and General Medicine.

David brings over 15 years of clinical trial operations experience in numerous therapeutic areas primarily associated with Oncology -- Supportive Care & Therapeutics, Diabetes/Obesity, Inflammation, General Medicine, Bone Metabolism, and HIV/AIDS. He brings extensive experience in the development and management of Clinical Field Operations, Clinical Trials Operations, and Clinical Drug Development in Phases I-III.

Neil H. Shusterman, M.D.

In his new role, Dr. Shusterman will have oversight of Medical, Regulatory Affairs, Medical Writing and Drug Safety Services.

Prior to joining RPS, Dr. Shusterman was Senior Vice President of Clinical Development at the Forest Research Institute of Forest Laboratories, Inc. At Forest Laboratories he also served as Senior Vice President, Clinical Development, Safety and Operations and Vice President, Internal Medicine Therapeutic Area, Clinical Development and Medical Affairs. Before joining Forest, Dr. Shusterman held the position of Vice President, Cardiovascular Therapeutic Area, North American Medical Affairs, R&D, at GlaxoSmithKline. He brings extensive knowledge and experience in clinical research and development, as well as therapeutic expertise in internal medicine, nephrology and cardiovascular medicine.

Additionally, Dr. Shusterman has served as an adjunct Assistant Professor in the Department of Medicine at the University of Pennsylvania's School of Medicine in Philadelphia, PA, and has held Administrative Appointments such as Chief Executive Officer, University of Pennsylvania Outpatient Dialysis Unit. He is board certified in Internal Medicine and Nephrology.

About RPS

RPS (ReSearch Pharmaceutical Services, Inc.), The Next Generation CRO, provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology and Medical Device industries. By combining an experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our clients both integrated and full service global outsourcing solutions.

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kellogg School of Management Expert Finds Multicultural Experience Enhances Creativity
2. Study by Texas A&M University-Corpus Christi Confirms Training With Vision Software Enhances Hitting Skills
3. New VP of Operations Enhances The Beryl Companies Leadership Team
4. CAS New SciFinder(R) Enhances the Research Experience Via the Web
5. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
6. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
7. AT&T Enhances Performance for LAMMICO With Upgraded Network Services
8. Computer-Aided Detection in Screening Mammography Enhances Performance of a Single Reader
9. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
10. Technique enhances digital television viewing for visually-impaired
11. Z-shaped incision enhances minimally invasive surgery
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with ... the 2016 Building Better Radiology Marketing Programs meeting will showcase some ... March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session ...
(Date:11/27/2015)... ... 2015 , ... The moment you stop improving is the ... the needs of advisers and clients but going above and beyond to find ... service. However, there's always room for improvement, which is why the entire Consulting ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... most successful and prominent nonprofit healthcare organizations in the country. They have overseen ... various organizations, and helped advance the healthcare industry as a whole through their ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... YORK , November 27, 2015 ... system is set to go online. The potential to ... processes is vast and far from fully exploited as ... to patient health records, either via mobile tablet or ... ) --> ) --> ...
(Date:11/26/2015)... , November 27, 2015 ... --> --> ... emergency response system (PERS) market ... for 5 years with APAC ... expected to see a high ...
(Date:11/26/2015)... 2015 --> --> ... to find optimal contrast weighting of MRI for patients ... signed a research agreement with SyntheticMR in order to use ... it is possible to generate multiple contrast images from a ... has left, thus making it possible to both fine tune ...
Breaking Medicine Technology: